---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-011391"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2025-05-19T23:59:59+00:00"
generated_at: "2026-05-21T02:38:45.117296+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aspira Q1 revenue up 5.9% to $2.28M; gross margin 68.5%, cash burn reduced 30%

## Summary
- Revenue $2.28M vs $2.15M YoY (+5.9%), driven by select price increases and 94% jump in sales per FTE.
- Gross profit $1.6M (+28.5%); gross margin improved to 68.5% from 56.4% due to one-time accrual reduction and OvaWatch profitability.
- Operating expenses fell 19% to $4.8M (vs $5.9M); operating cash burn reduced 30% to $3.1M.
- Cash on hand rose to $3.3M from $1.8M; current liabilities decreased 30% to $3.8M.
- CEO Mike Buhle cited early traction under new leadership; ENDOInform R&D updates expected by end of 2025.

## SEC filing metadata
- accession: 0001641172-25-011391
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2025-05-19T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000164117225011391/0001641172-25-011391-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000164117225011391/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-011391
- JSON: https://secwatch.observer/filing/0001641172-25-011391.json
- Plain text: https://secwatch.observer/filing/0001641172-25-011391.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.